SciClone infectious news

SciClone agreed to pay $12.8 million to settle an SEC investigation into whether historical sales and marketing in SciClone’s China operations violated the Foreign Corrupt Practices Act. The company “neither admits nor denies it engaged in any wrongdoing.” SciClone also said the Department of Justice completed a related investigation and declined to pursue action against the company. Both agencies had been investigating SciClone since 2010.

Separately, the company hired Lazard to help the company seek strategic alternatives. The company does “not plan to comment further on the strategic review or potential outcome until the process has been completed.” ...